back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-13 15:19 Tx date 2023-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,105 vol |
||
| Filed 2023-12-13 15:00 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+19,500 vol |
25,400 | |
| Filed 2023-12-13 14:59 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,048
+72,800 vol $1.91 each |
602,183 | |
| Filed 2023-12-12 09:57 Tx date 2023-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,105 vol |
||
| Filed 2023-08-18 11:47 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:46 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:45 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
529,383 | |
| Filed 2022-12-13 12:20 Tx date 2022-12-12 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-526 vol |
507,683 | |
| Filed 2022-12-13 12:16 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
508,209 | |
| Filed 2022-06-17 11:22 Tx date 2022-06-16 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,851
+4,200 vol $1.16 each |
4,200 | |
| Filed 2022-06-17 11:21 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-09 10:07 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-77,997.66
-10,526 vol $7.41 each |
428,209 | |
| Filed 2021-12-15 09:50 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-842 vol |
438,735 | |
| Filed 2021-12-13 17:40 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
439,577 | |
| Filed 2021-03-12 18:11 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+45,000 vol $3.40 each |
384,577 | |
| Filed 2021-02-26 15:06 Tx date 2021-02-24 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,500
-10,000 vol $1.45 each |
339,577 | |
| Filed 2021-02-14 16:32 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
349,577 | |
| Filed 2020-12-15 10:17 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
||
| Filed 2020-12-16 16:59 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,000
+200,000 vol $3.17 each |
349,787 | |
| Filed 2020-12-15 10:17 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
149,577 | |
| Filed 2020-11-10 09:55 Tx date 2020-11-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,775.50
-210 vol $46.55 each |
149,787 | |
| Filed 2020-03-09 10:13 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
159,997 | |
| Filed 2019-12-18 15:49 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
||
| Filed 2020-01-08 14:35 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,500
-10,000 vol $1.45 each |
149,997 | |
| Filed 2019-12-18 15:49 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
159,997 | |
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
59,997 |